| Code | 3004D | ||||||||||
| MA number | 59/0380/19-S | ||||||||||
| Product Form: | cps pld 30x5 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 03.12.2019 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Dailiport_04.2025.pdf
|
| PIL: |
PIL_Dailiport_04.2025.pdf
|
| Safety feature | Yes |
| Data update: | 31.05.2024 |
